Trial Details
COMPLETEDBasic Information
| Clinical ID | c402 |
|---|---|
| Identifier | NCT02461758 |
| Trial Title | Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD) |
| Interventions | BIOLOGICAL: Standard dose Influenza vaccine (SDIV)|BIOLOGICAL: High dose influenza vaccine (HDIV) |
Participant Information
| Sponsor | University of Wisconsin, Madison |
|---|---|
| City | Madison |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-10-16 |
|---|---|
| Primary Completion Date | 2025-06-18 |
| Completion Date | 2025-07-18 |